Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aildenafil pharmacokinetics in special adult male populations
ChiCTR2300071119Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aildenafil in erectile dysfunction (ED) (3 arms), sponsored by Peking University First Hospital. Primary endpoints: Cmax, AUC0-t and 9 more. Started May 2023; status: recruiting.
02
Drugs
aildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR2300071119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071119.